Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study

NCT04539964 is registered in ClinicalTrials.gov with SetPoint Medical Corporation as lead sponsor.

NCT NCT04539964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Lead sponsor
SetPoint Medical Corporation
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 11, 2021
Completion date
October 31, 2027
Enrollment
243 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis